Page 3 of 3

Posted: Sat Nov 21, 2009 1:12 pm
by mrhodes40
Here's an abstract from another one found on pubmed
Effects of 1alpha,25 dihydroxyvitamin D3 on the expression of HO-1 and GFAP in glial cells of the photothrombotically lesioned cerebral cortex.
PMID 15531134
Abstract In ischemic cerebral injuries a cascade of degenerative mechanisms, all participating in the development of oxidative stress, influence the condition of the tissue. The survival of viable tissue affected by secondary injury largely depends on the balance between endogenous protective mechanisms and the ongoing degenerative processes. The inducible enzyme, heme oxygenase-1 metabolizes and thus detoxifies free heme to the powerful endogenous antioxidants biliverdin and bilirubin therefore enhancing neuroprotection. The secosteroid 1alpha,25-dihydroxyvitamin D3 (1,25-D3) is a modulator of the immune system and also exhibits a strong potential for neuroprotection as recently shown in the MCAO model of cerebral ischemia. We studied the effects of 1,25-D3 treatment on heme oxygenase-1 expression following focal cortical ischemia elicited by photothrombosis. Postlesional treatment with 1,25-D3 (4 microg/kg body weight) resulted in a transient, but significant upregulation of glial heme oxygenase-1 immunoreactivity concomitant with a reduction in glial fibrillary acidic protein immunoreactivity in remote cortical regions affected by a secondary spread of injury, whereas the size of the lesion's core remained unaffected. 1,25-D3 did not produce a temporal shift or extension of injury-related heme oxygenase-1 responses, indicating that 1,25-D3 did not prolong ischemia-related heme oxygenase-1 expression. In contrast to glial heme oxygenase-1 upregulation, glial fibrillary acidic protein, a sensitive marker for reactive gliosis, was significantly reduced. These findings support an additional protective action of 1,25-D3 at the cellular level in regions affected by secondary injury-related responses.
Authors Karl Zilles , Otto-W Witte , Hans-J Bidmon , Evelyn Oermann
Journal Title Journal of chemical neuroanatomy
This one says that the resulting damage is the sum of the inside the body (endogenous) protective mechanisms and the amount of degeneration caused by the damage...

They caused a type of blood clot to occur then watched the lesion that developed from it.

If they gave active vitamin d after the lesion was present the core of the lesion did not change but the secondary expansion of the lesion was reduced by reducing the gliosis which scarring to the nerve. In other words it didn't heal the initial brain lesion injury but it reduced the secondary injury.

Posted: Sat Nov 21, 2009 2:36 pm
by ikulo
I remember reading a study that suggested that Vitamin D is integral in the formation of collagen, which is necessary for proper development of blood vessels, veins, etc. Also, there's an article out there that suggests that the most relevant measure of vitamin D is when the person is still in the womb or still very very young.. in fact I believe a larger number of MS'ers are born in the spring time, suggesting that the MSer did not get enough vitamin D in the womb because of the winter months. So, I suppose it would follow that in the womb an MS'er didn't get enough vitamin D, perhaps leading to lower levels of collagen??, and then maybe some type of event in the life that caused the jugulars, etc to collapse or become damaged because the collagen levels were low or the body didn't have a way to fix them?? Not sure if that make sense, what do you guys think?

ok, back to studying for finals.

Posted: Sat Nov 21, 2009 5:30 pm
by mrhodes40
Good thought!
From the Bologna conference finalized notes Cheer took saved on the research thread Dr Gabbiani said
By red staining for collagen and using unpolarized and polarized light, he saw that there is less collagen 1 type fibers in the MS jugular vein tissue, and more collagen III fibers in MS. This is the exact opposite of the controls.

Connective tissue in MS switches from collagen I to collagen III and this takes place in the IJVs. This switch also happens in fibromatosis, colloids and hypertrophied scars, and this remodeling may play a role in CCSVI disturbances
The problem is not that the viatmin d material disproves CCSVI--it is that no one has looked at vitamin D from this perspective. It is a rich area to find associations with CCSVI, there are many ways it may play in to this model.

Posted: Sat Nov 21, 2009 6:58 pm
by ikulo
Mr.Rhodes - your note on Collagen I and III is echoed in this study:
Comparison of collagen subtype I and III presence in varicose and non-varicose vein walls.

Haviarova Z, Janega P, Durdik S, Kovac P, Mraz P, Stvrtinova V.

Institute of Anatomy, Faculty of Medicine, Comenius University, Bratislava, Slovakia. zora.haviarova@fmed.uniba.sk

STUDY OBJECTIVES: The connective tissue alterations in varicose vein wall are supposed to be one of the main causes of primary varicose vein (main sign of human lower limbs chronic venous insufficency). METHODS: 5 varicose vein samples from 5 patients undergoing stripping surgery of long saphenous vein were compared with 5 control samples of healthy (non-dilated) long saphenous veins from necroptic material (with no history of varicosis). They were fixed in a Baker solution, processed by use of light microscopic method, cut to ultra-thin sections (4-5 microm) and stained with PicroSirius Red for collagen. Sections were scanned with light microscope (Leica, Germany) and camera Canon S50 (Germany) and analysed by morphometric programme Image J v.1.38g (National Institute of Health, USA). RESULTS: In the group of healthy (non-dilated) veins the mean collagen I/III ratio value was 31.40 and in the group of varicose veins the mean collagen I/III ratio was 12.35; the difference is statistically significant: healthy veins contain significantly more of collagen subtype I and varicose veins contain significantly more of collagen subtype III in their walls. CONCLUSION: The statistically significant difference in the collagen I/III ratio between the groups of healthy (non-dilated) and varicose (dilated) vein walls is worthy of further following (Tab. 2, Fig. 7, Ref. 12). Full Text (Free, PDF) www.bmj.sk.

Posted: Sat Nov 21, 2009 8:42 pm
by mrhodes40
Now it is a chicken and egg question: does the collagen characteristic change in the face of venous pressure or does the collagen be different to begin with and result in the vericosities?

This is not answered conclusively in venous ulcer research yet so I assume will remain an unanswered thing for MS for a while anyway.

I am a lady, Marie Rhodes I have been 40 for 9 years now :wink:

Posted: Sat Nov 21, 2009 10:33 pm
by ikulo
haha, sorry Marie! I saw Mrh... and I just thought Mr. :) Oh sure, blame the new guy! :lol:

As far as the question, I have no idea. I did try to find additional reports linking Vitamin D to venous malformation, etc. but nothing was coming up. Perhaps someone with some experience or knowledge in this topic could provide some clues.

Posted: Sun Nov 22, 2009 1:00 am
by ErikaSlovakia
ikulo wrote:
Haviarova Z, Janega P, Durdik S, Kovac P, Mraz P, Stvrtinova V.

Institute of Anatomy, Faculty of Medicine, Comenius University, Bratislava, Slovakia. zora.haviarova@fmed.uniba.sk
Hi ikulo,
this lady: Stvrtinova V. is the prof. Dr. Viera Stvrtinova, PhD. who I visited at the beginning of my story - she is an Angiologist.
She knows Dr. Simka in person. They also met in Monaco during a conference of Phlebology this August. She was willing to help me with the health insurance but they made it so complicated that at the end it was not possible.
I am in contact with her. I would like to read this in Slovak. I will send an e-mail to Mrs. Haviarova to get the research.
Erika[/u]

Posted: Sun Nov 22, 2009 9:35 am
by JSTCD
I don't think vein formation is entirly genetic. It also has something do do with how you develop.

I would think that in a HOT climate, you would need to increase blood flow to the brain to cool it, and a child developing in that environment might develop wider veins.

In a cold Climate the opposite is true, so one would expect to develop smaller veins. Add some sort of genetic pre-disposition and voila CCSVI.

Once you finished growing, vein size would be fixed, hence the protection of latitude depending on where you grew up, not where you live as an adult.

Posted: Sun Nov 22, 2009 9:52 am
by mrhodes40
Now that is an interesting theory. When you start bending your head around the question "how might vit D and geographic location play a role in CCSVI" all kinds of things come up...researchers will have this happen too I think :D

Posted: Sun Nov 22, 2009 6:55 pm
by radeck
Quick request for clarification, is the type of collagen change observed in CCSVI by Gabbiani and others of the same type as that in varicosed veins, or different?

Re:

Posted: Sat Nov 21, 2015 9:55 am
by chenman
Hello Marie,
I am new to this forum, was looking for "varicosis" and found this thread of 2009.
After searching for MS causes for more than 20 years I want to pass on some info:

(0. The basis for MS is laid until about puberty, textbook knowledge.)

1. Identical = monozygous twins (MZ) are typically discordant for MS; recent analysis from Sweden: if one twin has MS, the risk of the other one is below 20%. And their common environment at home - food etc. - is without effect on the MS risk. The twins have the same sun exposure and vitamin D supply by food: Forget sun and vitamin D as CAUSE of MS; however, they may influence the course of MS later on...
These facts leave few alternatives for the "all or none" exogenous cause of MS. Accidents? No, would have been clarified a century ago...
If you think it over it seems probable that one of the MZ aquires a relatively rare infection outside of the home (or kindergarten, school...; NOT a typical childhood disease), an infection which in childhood until puberty is either not recognised or forgotten many years later ...

2. What comes to mind are tick bites which may transmit quite a number of chronic infections. Thinking along these lines Prof. Gabriel Steiner (1883-1965), at that time at the Univ. of Heidelberg / Germany, in 1922(!) published the analysis of some 90 histories of MS patients suggesting that the chronic infection he suspected as the cause of MS (in analogy to MS-like symptomatology in some patients with late neuro syphilis) seems to be transmitted by ticks.
(Btw: at that time more men had MS than women - which dictates that the cause of MS has impacted women more often in recent decades to yield 2-3(-4) times higher incidence in women now.)

3. Because Prof. G.Steiner suspected spirochetes as the cause of MS (similar to T.pallidum discovered 1905 in Berlin as the cause of syphilis), and spirochetes are very slim, at or below the resolution of light microscopy, he developed a silver staining method to increase the diameter of those very slim bacteria: Late in the 1920s he started to publish his findings.
As an old man he summed up the results of his life-long research on the etiology of MS in 1962 (now at Detroit), in German (he was 53 when he emigrated to the USA, so he stuck with his native language in explaining complex findings, thoughts...):
http://link.springer.com/book/10.1007%2 ... 42-87571-7
When you scroll down to the chapter "Die Spirochaeta myelo...", click on "Look inside" and go to the second page offered for preview (p.37 in the book), you see 4x4 =16 micrographs of the spirochetes IN active MS lesions of autopsied brains.
Further on in the book these spirochetes are classified as borreliae. (G.Steiner also lists more than half a dozen results of other groups supporting his findings, i.e. from Stanford 1958:
http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/13608292/

4. Meanwhile there have been more supportive findings, i.e. by Brorson et al. from Norway:
http://www.ncbi.nlm.nih.gov/pubmed/11787831
The evidence for borreliae (transmitted by ticks...) as cause of MS is overwhelming by now - my impression after more than 2 decades of searching.
Could it be chance that Willy Burgdorfer in ?1981 found borreliae in ticks he had collected? And that these borreliae soon were identified as the cause of "Lyme disease", including late (CNS) neuroboreliosis? And that such neuroborreliosis is indistiguishable from MS (as was true for some cases of late neurosyphilis, giving rise to the search of Gabriel Steiner in the first place)?

5. Meanwhile quite a number of studies show mino- and doxycycline to be highly effective in (active) MS. Doxycycline has been the standard therapy for tick borreliosis for decades by now: 2-3 weeks of 200 or 300 mg per day (not for children...).
Doxycycline is to be preferred, especially in MS, because minocycline quite often causes vertigo, which could be a symptom of MS...

6. B.burgdorferi is transmitted by hard ticks, abundant in moderate climate with high humidity (ticks cannot drink, as far as I know, will dehydrate and die when the soil where they hide dries out).
MS is distributed geografically following hard tick prevalence as well as genetic predisposition and the activity patterns of local people at risk. (I.e. walking dogs in "tick habitats", including many parks in cities.)
------------------------------------------------------------

Details "fill books", but the consequences should be clear from the facts listed above.
(I myself have done accordingly, starting in 1993. One of my observations: neurological symptoms suggestive of MS started in the 1980s in parallel with quite rapidly advancing varicosis in my lower legs - where dozens of ticks had bitten me from childhood onward - but I was always sero-negative for borreliosis, tested repeatedly 1991...1996, including CSF twice. Looking back the varicosis stopped advancing after 1993...)

I wonder if this information will be wellcomed on this board - in Germany it seems to be hated, quite strange... (However, a few persons with MS have tried 2-3 weeks of doxycycline, and ?all report improvements, some "dramatic" like "feel like living again", brain fog gone, slow improvement of impairment...
In one postmenopausal SP-MS patient in California, who was on Teriflunomide 14 mg/d before, the progression seems to have stopped, as far as can be judged after just 2 years. But she has depleted her iron stores by blood donations, in addition, as I did 2 decades ago, so the effect could result from more than just taking doxycyline...)

My goal: start a turnaround towards "a world without MS".
chenman
mrhodes40 wrote:This has actually been tossed out about three times in the forum here as the reason this can't be the cause of MS.

I don't know if CCSVI is the cause of MS but I know it is associated. But there is a significant difference in vitamin d levels of people in lower latitudes and I assume it has to do with that which is exactly where the rest of MS research is with regards to vitamin D...in other words they have now figured out that vitamin d levels are low that d levels have something to do with it but they do not know exactly, precisely what it has to do with lesion formation.

The different theories have different ideas, for example if you are a germ person it is all about cathelicidins, if you are autoimmune it has to do probably with the overactive immunity being allowed to go out of control because d dampens it somewhat.

Whether MS is autoimmune, germs or CCSVI or a combination of those, in some way vitamin D plays in, and no one knows exactly how yet. But ... (... ...)
......

Re: Re:

Posted: Mon Nov 23, 2015 7:51 am
by Cece
chenman wrote:My goal: start a turnaround towards "a world without MS".
chenman
A worthy goal indeed. All the best.

Re: Re:

Posted: Mon Nov 23, 2015 8:29 am
by 1eye
Cece wrote:
chenman wrote:My goal: start a turnaround towards "a world without MS".
chenman
A worthy goal indeed. All the best.
Of course, not a lot is ever proof.

There was a Japanese study that found over multiple patients a difference between the gut bacteria of MS patients and that of normal controls, using DNA for strain identification.

It may not be wise to drop antibacterial nukes on the gut, unless the bacterial populations can be re-balanced in the process.

Re: Re:

Posted: Mon Nov 23, 2015 12:12 pm
by chenman
1eye wrote:
Cece wrote:
chenman wrote:My goal: start a turnaround towards "a world without MS".
chenman
A worthy goal indeed. All the best.
Of course, not a lot is ever proof.

There was a Japanese study that found over multiple patients a difference between the gut bacteria of MS patients and that of normal controls, using DNA for strain identification.

It may not be wise to drop antibacterial nukes on the gut, unless the bacterial populations can be re-balanced in the process.
Hi leye,
I am talking about doxycycline, which is lipophilic: It ist absorbed almost 100% in the stomach and upper gut, does not reach the lower parts where the bacteria are.

I.e. see this ?2 year tolerability study with continuous dosing
http://www.karger.com/?DOI=10.1159/000113733

My strategy is different: doxy for 2-3 weeks, only once, according to guidelines for "Lyme", for a reference.
After a long pause I started "pulsing": doxy for just 2 days per month - no risk whatsoever (if you stay out of the full sun for ca. 3days - and phototoxicity is quite rare, even in SF / California the whole year over, cf. the study mentioned above).